Table 1. The adverse outcomes reported in the included trials.
Trials | Reported Outcomes | Follow up period (months) |
---|---|---|
SCORPIUS | Mortality, MI and TLR | 1, 8 and 12 |
PASEO | Mortality, MI, TLR, MACEs, ST | 12 |
DIABETES | MACEs, revascularization | 1 and 9 |
HORIZONS-AMI | Mortality, MACEs, TLR, TVR, ST, MI | 12 |
PRODIGY | TVR, TLR, ST | 24 |
TAXUS VI | Mortality, MACEs, TVR, TLR, MI | 1 and 9 |
TAXUS IV | MACEs, TVR, TLR | 12 |
SIRIUS | MACEs, TLR | 9 |
STONE2005 | Mortality, MACEs, TLR, TVR, MI, ST | 1 and 9 |
STONE2004 | Mortality, MI, ST, TVR, TLR, MACEs | 9 |